Clinical trial
Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who…
NCT00031811 · OHSU Knight Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00031811 |
|---|---|
| Title | Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast Cancer |
| Official title | Breast Cancer Survivors: Exercise and Raloxifene |
| Lead sponsor | OHSU Knight Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Breast Cancer, Menopausal Symptoms, Osteoporosis |
| Intervention type | Drug, Procedure |
| Interventions | raloxifene, quality-of-life assessment |
| Enrollment | 80 |
| Start date | Mar 1, 2001 |
| Primary completion | Apr 1, 2003 |
| Completion | Apr 1, 2003 |
| First posted | Aug 6, 2003 |
| Last update posted | May 28, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: